OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis
Harry Crane, Guy D. Eslick, Cameron Gofton, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 436-448
Open Access | Times Cited: 14
Harry Crane, Guy D. Eslick, Cameron Gofton, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 436-448
Open Access | Times Cited: 14
Showing 14 citing articles:
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
George Lau, Shuntaro Obi, Jian Zhou, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1661-1683
Open Access | Times Cited: 7
George Lau, Shuntaro Obi, Jian Zhou, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1661-1683
Open Access | Times Cited: 7
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Maito Suoh, Saeed Esmaili, Mohammed Eslam, et al.
Hepatology International (2024)
Open Access | Times Cited: 4
Maito Suoh, Saeed Esmaili, Mohammed Eslam, et al.
Hepatology International (2024)
Open Access | Times Cited: 4
Global burden and international disparities in NASH-associated liver Cancer: mortality trends (1990–2021) and future projections to 2045
Qilong Nie, Yongwen Jiang, Mingyang Li, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Qilong Nie, Yongwen Jiang, Mingyang Li, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Associations of MAFLD subtypes and air pollutants with multi-system morbidity and all-cause mortality: A prospective cohort study
Jingyi Zhang, Shanshan Ran, Shengtao Wei, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 291, pp. 117893-117893
Open Access
Jingyi Zhang, Shanshan Ran, Shengtao Wei, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 291, pp. 117893-117893
Open Access
Exploring Emerging Frontiers in Hepatology: iLIVER's Continuing Journey
Ming-Da Wang, Xin‐Fei Xu, Lei Cai, et al.
iLiver (2025), pp. 100148-100148
Open Access
Ming-Da Wang, Xin‐Fei Xu, Lei Cai, et al.
iLiver (2025), pp. 100148-100148
Open Access
A review of image guidance and localization methods for liver puncture robots
Yongde Zhang, Jiabin Yang, Huang Xue-quan, et al.
Journal of Robotic Surgery (2025) Vol. 19, Iss. 1
Closed Access
Yongde Zhang, Jiabin Yang, Huang Xue-quan, et al.
Journal of Robotic Surgery (2025) Vol. 19, Iss. 1
Closed Access
Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP‐1RA in CHB and T2DM Patients
Byungyoon Yun, Juyeon Oh, Heejoo Park, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Byungyoon Yun, Juyeon Oh, Heejoo Park, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 705-708
Open Access | Times Cited: 2
Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 705-708
Open Access | Times Cited: 2
Splanchnic inflammatory syndrome and the not-so-silent risk of cancer
Richard C. Semelka, Miguel Ramalho
Gastroenterology & Hepatology Open Access (2024) Vol. 15, Iss. 3, pp. 63-64
Open Access | Times Cited: 2
Richard C. Semelka, Miguel Ramalho
Gastroenterology & Hepatology Open Access (2024) Vol. 15, Iss. 3, pp. 63-64
Open Access | Times Cited: 2
Unraveling the Epidemiology of Metabolic Dysfunction-Associated Liver Cancer: Insights from Mixed Etiologies, Regional Variations, and Gender Disparities
Gong Feng, Ya-Fei Fan, Ru-Xin Li, et al.
iLiver (2024) Vol. 3, Iss. 3, pp. 100113-100113
Open Access | Times Cited: 2
Gong Feng, Ya-Fei Fan, Ru-Xin Li, et al.
iLiver (2024) Vol. 3, Iss. 3, pp. 100113-100113
Open Access | Times Cited: 2
Impact of occult hepatitis B virus infection and high-fat diet on hepatocellular carcinoma development
Kun Chen, Chunfeng Qu
Hepatoma Research (2024)
Open Access | Times Cited: 1
Kun Chen, Chunfeng Qu
Hepatoma Research (2024)
Open Access | Times Cited: 1
Association of the Number of Concurrent Metabolic Syndrome Risk Factors with Textbook Outcomes Following Liver Resection for Patients with Hepatocellular Carcinoma: A Multicenter Study
Zhan-Cheng Qiu, Jun-Long Dai, Yu Zhang, et al.
Annals of Surgical Oncology (2024)
Closed Access | Times Cited: 1
Zhan-Cheng Qiu, Jun-Long Dai, Yu Zhang, et al.
Annals of Surgical Oncology (2024)
Closed Access | Times Cited: 1
Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis
Muhammed Shabil, Mahalaqua Nazli Khatib, Suhas Ballal, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Muhammed Shabil, Mahalaqua Nazli Khatib, Suhas Ballal, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
MAFLD-related hepatocellular carcinoma in China: An increasing problem
Xiangyu Wu, Wenjing Ni, Qianqian Chen, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 965-969
Open Access
Xiangyu Wu, Wenjing Ni, Qianqian Chen, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 965-969
Open Access
Deciphering the roles of neddylation modification in hepatocellular carcinoma: Molecular mechanisms and targeted therapeutics
Wenxin Wu, Xuelin Wang, Ruijie Ma, et al.
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101483-101483
Open Access
Wenxin Wu, Xuelin Wang, Ruijie Ma, et al.
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101483-101483
Open Access
